Patent · US Revoked

Modified oligonucleotides targeting SNPs

US11767527B2 · kind B2 · utility

0Cited by
66References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 9, 2019
Grant dateSep 26, 2023
Priority date
Expiry dateApr 4, 2042

Classification

  • Technology area (CPC —)General

Abstract

Novel oligonucleotides that enhance silencing of the expression of a gene containing a single nucleotide polymorphism (SNP) relative to the expression of the corresponding wild-type gene are provided. Methods of using novel oligonucleotides that enhance silencing of the expression of a gene containing a SNP relative to the expression of the corresponding wild-type gene are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.